Last reviewed · How we verify

NCT06040749

Virtual Sport for Adults ≥ 50 Years With Spinal Cord Injury

Completed NA Last updated 6 April 2025
What this trial tests

NA trial testing Virtual group-based handcycling in Spinal Cord Injury in 5 participants. Completed in 30 September 2024.

Timeline
5 May 2023
Primary endpoint
30 September 2024
30 September 2024

Quick facts

Lead sponsorUniversity Health Network, Toronto
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment5
Start date5 May 2023
Primary completion30 September 2024
Estimated completion30 September 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University Health Network, Toronto

Who can join

50 and older, any sex, with Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sport is a physical activity that has many physical, psychological and social benefits for those with spinal cord injury (SCI). However, most sport research involves people with SCI who are \<50 years old. This is a problem because many people are \>50 years old when first injured. Moreover, people with a SCI are now living longer lives, meaning they also experience more health challenges. Unfortunately, there is limited research studying the impact of sport for adults with SCI aged ≥50 years old.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injury

Currently open trials in the same condition.

Other University Health Network, Toronto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06040749.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing